Short Interest in BioPharma Credit PLC (OTCMKTS:BOPCF) Grows By 1,216.1%

BioPharma Credit PLC (OTCMKTS:BOPCF) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 776,879 shares, an increase of 1,216.1% from the March 15th total of 59,027 shares. Based on an average daily volume of 646,165 shares, the short-interest ratio is presently 1.2 days.

BioPharma Credit Stock Performance

Shares of BOPCF opened at $0.96 on Friday. BioPharma Credit has a 12 month low of $0.78 and a 12 month high of $1.00. The stock has a fifty day moving average price of $0.89 and a 200-day moving average price of $0.90.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.